Amneal receives FDA approval for generic Indocin

BRIDGEWATER, N.J. — The Food and Drug Administration has approved a generic drug for pain and inflammatory diseases made by Amneal Pharmaceuticals, Amneal said Thursday.

The FDA approved indomethacin extended-release capsules in the 75-mg strength. The drug is used to treat pain associated with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, bursitis and tendonitis.

The drug is a generic version of Merck’s Indocin. Annual sales of indomethacin ER capsules were $41.5 million during the 12-month period ended in October 2010, according to IMS Health.

Recommended stories

Login or Register to post a comment.